Publicaciones (55) Publicaciones de SUSANA TORRADO DURÁN

2023

  1. Effect of Clindamycin on Intestinal Microbiome and Miltefosine Pharmacology in Hamsters Infected with Leishmania infantum

    Antibiotics, Vol. 12, Núm. 2

2022

  1. In Vitro and In Vivo Characteristics of Olive Oil as Excipient for Topical Administration

    Pharmaceutics, Vol. 14, Núm. 12

  2. Leishmania infantum infection does not affect the main composition of the intestinal microbiome of the Syrian hamster

    Parasites and Vectors, Vol. 15, Núm. 1

2017

  1. Improvement of the surface hydrophilic properties of naproxen particles with addition of hydroxypropylmethyl cellulose and sodium dodecyl sulphate: In vitro and in vivo studies

    International Journal of Pharmaceutics, Vol. 529, Núm. 1-2, pp. 381-390

2016

  1. New Multi-Particle Systems for Colon-Targeted Meloxicam

    Journal of Applied Pharmacy, Vol. 8, Núm. 3, pp. 1-3

2015

  1. Novel solid dispersions of benznidazole: Preparation, dissolution profile and biological evaluation as alternative antichagasic drug delivery system

    Experimental Parasitology, Vol. 149, pp. 84-91

2014

  1. Development of novel benznidazole formulations: Physicochemical characterization and in vivo evaluation on parasitemia reduction in Chagas disease

    International Journal of Pharmaceutics, Vol. 472, Núm. 1-2, pp. 110-117

  2. Enhanced bioavailability and anthelmintic efficacy of mebendazole in redispersible microparticles with low-substituted hydroxypropylcellulose

    Drug Design, Development and Therapy, Vol. 8, pp. 1467-1479

2012

  1. Review of oral insulin delivery systems

    European Journal of Parenteral and Pharmaceutical Sciences, Vol. 17, Núm. 1, pp. 20-26

  2. The Influence of CYP2C19 Genetic Polymorphism on the Pharmacokinetics/- Pharmacodynamics of Proton Pump Inhibitor-Containing Helicobacter pylori Treat-ments

    Current Drug Metabolism, Vol. 13, Núm. 9, pp. 1303-1312

2011

  1. Changed crystallinity of mebendazole solid dispersion: Improved anthelmintic activity

    International Journal of Pharmaceutics, Vol. 403, Núm. 1-2, pp. 23-28

2010

  1. Influence of lactose addition to gentamicin-loaded acrylic bone cement on the kinetics of release of the antibiotic and the cement properties

    Acta Biomaterialia, Vol. 6, Núm. 3, pp. 804-811

2008

  1. Effects of hydroxypropyl-β-cyclodextrin on the chemical stability and the aqueous solubility of thalidomide enantiomers

    Pharmazie, Vol. 63, Núm. 7, pp. 511-513

2007

  1. Improvement of gentamicin poly(d,l-lactic-co-glycolic acid) microspheres for treatment of osteomyelitis induced by orthopedic procedures

    Biomaterials, Vol. 28, Núm. 5, pp. 877-885

2004

  1. Chitosan-poly(acrylic) acid polyionic complex: In vivo study to demonstrate prolonged gastric retention

    Biomaterials, Vol. 25, Núm. 5, pp. 917-923

  2. Microspheres containing insulin-like growth factor I for treatment of chronic neurodegeneration

    Biomaterials, Vol. 25, Núm. 4, pp. 707-714

  3. The effect of solubilization on the oral bioavailability of three benzimidazole carbamate drugs

    International Journal of Pharmaceutics, Vol. 272, Núm. 1-2, pp. 29-36

2003

  1. Composition of cholesterol and its precursors in ovine milk

    Lait, Vol. 83, Núm. 2, pp. 153-160

  2. Effect of two formulations of benzimidazole carbamates on the viability of cysts of Echinococcus granulosus in vivo

    Parasite, Vol. 10, Núm. 4, pp. 371-373

  3. Estudios de compatibilidad y determinación de monómero residual en cementos óseos modificados

    VI Congreso de la Sociedad Española de Farmacia Industrial y Galénica. 3ª Jornadas de Tecnología Farmecéutica. Granada, 9-11 de febrero de 2003.: Libro de Comunicaciones (Comares), pp. 129-132